Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Dec;41(12):1399-1405.
doi: 10.1007/s10096-022-04504-6. Epub 2022 Oct 7.

Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage

O Lima  1   2 , A Sousa  3   4 , A Filgueira  5 , M Carmen González-Novoa  6 , Celina Domínguez-López  4 , M Ávila-Nuñez  3 , M Represa  3 , P Rubiñán  3 , L Martínez-Lamas  7 , Sonia Pérez-Castro  6 , M Rubianes  3 , M T Pérez-Rodríguez  3   4
Affiliations
Observational Study

Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage

O Lima et al. Eur J Clin Microbiol Infect Dis. 2022 Dec.

Abstract

Carbapenem-resistant Enterobacterales (CRE) infections are a major health problem. Intestinal colonization is a key factor in developing infection. However, factors associated with persistent colonization by CRE are unknown. The aim of the study was to identify factors associated with persistent CRE gut colonization. This is a retrospective, single-centre, observational study of adult patients with CRE gut colonization between January 2015 and January 2020. Epidemiologic characteristics, comorbidities, infectious events, duration of hospitalization and antimicrobial treatment received in the follow-up period were collected. Colonization was defined as isolation in at least 2 rectal swab culture samples of CRE. Decolonization was defined as 3 negative rectal swab cultures or 2 negative cultures and a negative molecular test. A cohort of 86 patients with CRE gut colonization was selected: 44 patients with spontaneous decolonization (DC) and 42 patients with persistent colonization (PC). The mean follow-up period was 24 months (IQR 14-33) in the DC group vs. 25 months (IQR 16-36) in the PC group (p = 0.478). Patient characteristics were similar between both groups. Colonization by other MDR microorganisms was high (44 patients, 51%) and slightly more common in the PC group (PC 60% vs. DC 43%, p = 0.139). The use of ceftazidime-avibactam was more common among the PC group (PC 33% vs. DC 14%, p = 0.041). We observed a higher percentage of antimicrobial therapy in the previous 30 days (PC 68% vs. DC 57%, p = 0.371) and 90 days (PC 81% vs. DC 82%, p = 0.353) in the PC group. Multivariable analysis showed that patients that have received ceftazidime-avibactam therapy (OR 4.9 95% CI [1.45-16.39], p = 0.010), and those colonized by other MDR microorganisms (OR 2.5, 95% CI [0.96-6.25], p = 0.060) presented a higher risk of PC. Ceftazidime-avibactam use and colonization by other MDR microorganisms might be associated with CRE persistent gut colonization.

Keywords: Carbapenem-resistant; Enterobacterales; Gut carriage; OXA-48-type.

PubMed Disclaimer

References

    1. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL et al (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318–27. https://doi.org/10.1016/S1473-3099(17)30753-3 - DOI - PubMed
    1. Poirel L, Héritier C, Tolün V, Nordmann P (2004) Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48(1):15–22. https://doi.org/10.1128/aac.48.1.15-22.2004 - DOI - PubMed - PMC
    1. Miquel S-B, Matthew K, Carlos C-A, Antonella A, Martina B, Achilleas G et al (2020) Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis. PLoS ONE 15(1):e0227139. https://doi.org/10.1371/journal.pone.0227139 - DOI
    1. Rodríguez OL, Sousa A, Pérez-Rodríguez MT, Martínez-Lamas L, Suárez RL, Martínez CT et al (2021) Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia. Medicine (Baltimore) 100(14):e24880. https://doi.org/10.1097/MD.0000000000024880 - DOI
    1. Sousa A, Pérez-Rodríguez MT, Soto A, Rodríguez L, Pérez-Landeiro A, Martínez-Lamas L et al (2018) Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 73(11):3170–5. https://doi.org/10.1093/jac/dky295 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources